A Phase 1/2 Study of CPI-0610 With and Without Ruxolitinib in Patients With Hematologic and Myeloproliferative Malignancies
Constellation Pharmaceuticals
Constellation Pharmaceuticals
Thomas Jefferson University
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Northwestern University
Roswell Park Cancer Institute
Fred Hutchinson Cancer Center
H. Lee Moffitt Cancer Center and Research Institute
Jonsson Comprehensive Cancer Center
Case Comprehensive Cancer Center
Case Comprehensive Cancer Center
Canadian Cancer Trials Group
Fred Hutchinson Cancer Center
Mayo Clinic
University of Utah
Eli Lilly and Company
Wake Forest University Health Sciences
European Organisation for Research and Treatment of Cancer - EORTC
OHSU Knight Cancer Institute
California Cancer Consortium
UNC Lineberger Comprehensive Cancer Center
Traws Pharma, Inc.
Wake Forest University Health Sciences
Fred Hutchinson Cancer Center
Vanderbilt University Medical Center
Fred Hutchinson Cancer Center
Galena Biopharma, Inc.
Alliance for Clinical Trials in Oncology
Yale University
Hospital Israelita Albert Einstein
Alliance for Clinical Trials in Oncology
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
National Cancer Institute (NCI)
Children's Oncology Group
Indiana University
INSYS Therapeutics Inc
National Cancer Institute (NCI)
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Asan Medical Center
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Memorial Sloan Kettering Cancer Center
H. Lee Moffitt Cancer Center and Research Institute
European Organisation for Research and Treatment of Cancer - EORTC
European Organisation for Research and Treatment of Cancer - EORTC
Vanderbilt-Ingram Cancer Center
Northwestern University